Frontier Capital Management’s Aerie Pharmaceuticals AERI Stock Holding History
Bought
Maintained
Sold
Other funds holding AERI
DM
JG
GIM
Frontier Capital Management's AERI Position: Q4 2021 in Review
Frontier Capital Management sold out of Aerie Pharmaceuticals (AERI) in Q4 2021, closing a stake of 399,103 shares — an estimated $4.55M sold.
Frontier Capital Management first reported a position in AERI in Q2 2018 and held it in 14 quarters. The position peaked at $34.1M in Q3 2018. 129 funds tracked by Wall St. Rank hold AERI as of Q4 2021.
- Frontier Capital Management reported no remaining Aerie Pharmaceuticals position as of Q4 2021 after selling out during the quarter.
- Frontier Capital Management sold 399,103 Aerie Pharmaceuticals shares in Q4 2021, an estimated $4.55M.
- Frontier Capital Management first reported a position in Aerie Pharmaceuticals in Q2 2018 and held it in 14 quarters.
- Frontier Capital Management's Aerie Pharmaceuticals position peaked at $34.1M in Q3 2018.
- 129 funds tracked by Wall St. Rank held Aerie Pharmaceuticals as of Q4 2021.
Based on Frontier Capital Management's 13F filing for Q4 2021, filed 19 Jan 2022.